CAPITAL STOCK (Details Narrative)		3 Months Ended
	Dec. 28, 2021 shares	Mar. 31, 2021 shares	Mar. 31, 2022 $ / shares shares	Dec. 31, 2021 shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common Stock, Shares Authorized			480,000,000	480,000,000
Common Stock, Par or Stated Value Per Share | $ / shares			$ 0.001
Preferred Stock, Shares Authorized			20,000,000	20,000,000
Preferred Stock, Par or Stated Value Per Share | $ / shares			$ 0.001
Common Stock, Shares, Issued			50,634,536	50,605,965
Preferred Stock, Shares Issued			0	0
Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred Stock, Shares Authorized			1,000,000	1,000,000
Sapir Pharmaceuticals Inc [Member] | Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	1,000,000
Preferred Stock, Convertible, Conversion Ratio	450
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period		28,571